Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Articles
  • Issues
  • Blog

User menu

  • My Alerts
  • Log in

Search

  • Advanced search
Neurology: Education
Home
An open access peer-reviewed journal in neurologic and neuroscience training
  • My Alerts
  • Log in
Site Logo
  • Home
  • Articles
  • Issues
  • Blog

Disclosures

Stefan M. Pulst, MD, Dr med, FAAN


Scientific Advisory Boards
National Ataxia Foundation, Medical Research Advisory Board Hertie Institute for Brain Science, University of Tuebingen

Editorial Boards
Nature Clinical Practice Neurology; Editor: Neurology® Genetics

Patents
Nucleic acids encoding ataxin-2 binding proteins; Nucleic acid encoding Schwannomin-binding-proteins and products related thereto; Transgenic mouse expressing a polynucleotide encoding a human ataxin-2 polypeptide; Methods of detecting spinocerebellar ataxia-2 nucleic acids; Nucleic acid encoding spinocerebellar ataxia-2 and products related thereto; Schwannomin-binding-proteins; Compositions and methods for spinocerebellar ataxia; Methods For Modulating Ataxin2 Expression

Publishing Royalties
The Ataxias (Churchill Livingston, 2007), Genetics in Neurology (ANN Press, 2005), Genetics of Movement Disorders (Academic Press, 2003), Neurogenetics (Oxford University Press, 2000), Molecular Genetic Testing in Neurology, 2nd - 5th (AAN Press, 1996)

Research Support, Government Entities
2014-2021 National Institutes of Health (R37NS33123): Spinocerebellar ataxia type 2: gene and gene product. 9/30/14-6/30/2021. (Principal Investigator). 2018-2020 Harrington Discovery Institute Harrington Rare Disease Award: Development of a therapeutic for SCA2 and other rare neurodegenerative diseases. 3/1/18-2/28/20. Co-Investigator (Principal Investigator: D. Scoles) 2014-2021 National Institutes of Health Senator Jacob Javits Merit Award (R37 NS033123): Spinocerebellar ataxia type 2: gene and gene product. 10/1/14-6/30/21. Principal Investigator 2017-2020 National Institutes of Health (R21 NS104799-01): Deep cerebellar stimulation to treat degenerative cerebellar ataxia. 9/1/17-8/31/20. Principal Investigator 2017-2022 National Institutes of Health (R01 NS097903): RNA granules in cerebellar neurodegeneration. 4/1/17-3/31/22. Co-Investigator (Principal Investigator: D. Scoles) 2018-2021 National Institute of Neurological Disorders and Stroke (U01 NS103883): Antisense Oligonucleotides for treating spinocerebellar ataxia type 2. 2/15/18-1/31/21. Principal Investigator (with D. Scoles) 2018-2023 National Institute of Neurological Disorders and Stroke (U01 NS104326): Clinical Trial readiness for SCA1 and SCA3. 1/1/18-12/31/2023. Site Investigator (Principal Investigator: T. Ashizawa) 2018-2020 National Institute of Neurological Disorders and Stroke (R21NS103009): Characterization of ATXN2 as a target for ALS in SCA2 motor neurons. 7/1/18-6/30/21. Principal Investigator. 2019-2024 National Institute of Neurological Disorders and Stroke (R01 NS085054): Identifying symptomatic and neuroprotective strategies for cerebellar ataxia. 4/15/2019-3/31/2024. Site Investigator (Principal Investigator: V. Shakkottai) 2020-2023 CYDAN: SCA1 and SCA2 Studies With Cck1 Receptor Agonist. 1/1/2020-12/31/23. Principal Investigator

License fee payments, Technology or Inventions
University of Utah (license for invention & technologies

Royalty Payments, Technology or Inventions
University of Utah

 

Neurology: Education: 2 (1)

Articles

  • Articles
  • Issues
  • Popular Articles

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology: Education | Online ISSN: 2771-9979

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise